新兴再生医学的法律和监管挑战 糖尿病的再生医学解决方案
Rebecca L Thom1,2, Antonia J Cronin1,2,
1Peter Gorer Department of Immunobiology, MRC Centre for Transplantation, King's College London, London, United Kingdom.
Transplantation
|September 26, 2023
概括
再生医学为1型糖尿病治疗提供了新的希望. 将细胞疗法与医疗器械相结合,会带来监管障碍,需要对未来生物人工胰腺技术的进步进行范式转变.
科学领域:
- 再生医学是一种再生医学.
- 生物技术是生物技术.
- 医疗器械监管法规 医疗器械监管法规
背景情况:
- 1型糖尿病的治疗正在随着基于细胞的疗法而发展.
- 目前的欧洲法规将细胞疗法归类为先进治疗药物.
- 新兴技术将细胞疗法与医疗设备相结合,创造出混合产品.
研究的目的:
- 分析1型糖尿病中再生医学的监管环境.
- 检查混合细胞和设备疗法的挑战.
- 为新型生物人工胰腺技术提出必要的监管演变.
主要方法:
- 对欧洲先进治疗药物的现行法规的审查.
- 对基于细胞的疗法和移植的监管途径的分析.
- 检查通过将细胞疗法与医疗器械相结合而引入的监管复杂性.
主要成果:
- 已建立的基于细胞的疗法面临着监管途径.
- 混合细胞和设备产品引入了显著的监管复杂性.
- 现有的法律框架可能无法充分解决新兴的再生医学技术.
结论:
- 目前的法规对新型混合疗法提出了挑战.
- 需要进行重大的监管演变,才能实现再生医学在1型糖尿病方面的潜力.
- 调整监管范式对于推动生物人工胰腺发展至关重要.
更多相关视频
11:01Nutrient Regulation by Continuous Feeding for Large-scale Expansion of Mammalian Cells in Spheroids
Published on: September 25, 2016
7.8K
04:09Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers
Published on: March 3, 2023
2.9K
相关概念视频
Stem Cell Therapy for Tissue Regeneration
4.1K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K
Stem Cell Culture
5.2K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
5.2K
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
Induced Pluripotent Stem Cells
4.1K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.1K
Pathophysiology of Diabetes
971
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
971
Embryonic Stem Cells
3.6K
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
3.6K
